Skip to main content
OpenTrials

Clinical trial condition

Pituitary ACTH Hypersecretion

Explore clinical trials studying Pituitary ACTH Hypersecretion. Study availability and eligibility vary by location and protocol.

46 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Pituitary ACTH Hypersecretion trial results

Completed

A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome

NCT03697109

Conditions
ACTH Syndrome, Ectopic, Adrenal Gland Diseases, Adrenocortical Hyperfunction, +20 more
Locations
  • Site 21 Phoenix, Arizona, United States
  • Site 36 Los Angeles, California, United States
  • Site 68 Torrance, California, United States
  • Site 10 Miami, Florida, United States
View all 64 locations
View Trial Details
Completed

Open-label Treatment in Cushing's Syndrome

NCT03621280

Conditions
Adrenal Gland Diseases, Adrenocortical Hyperfunction, Brain Diseases, +9 more
Locations
  • The Center for Diabetes and Endocrine Care Fort Lauderdale, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • University of New Mexico HSC - HSC Sponsored Projects Office Albuquerque, New Mexico, United States
View all 30 locations
View Trial Details
Completed

Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease

NCT02310269

Conditions
Adrenal Gland Diseases, Adrenocortical Hyperfunction, Brain Diseases, +8 more
Locations
  • St Josephs Hospital and Medical Center Phoenix, Arizona, United States
  • University of Southern California CSOM230B2410 - SC Los Angeles, California, United States
  • Massachusetts General Hospital SC - SOM230B2410 Boston, Massachusetts, United States
  • Ohio State University SC - SOM230B2410 Columbus, Ohio, United States
View all 54 locations
View Trial Details
Completed

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

NCT01794793

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +50 more
Locations
  • Ximed Research SC - SOM230B2412 La Jolla, California, United States
  • Cedars Sinai Medical Center Cedars Sinai 4 Los Angeles, California, United States
  • Stanford Universtiy Medical Center Stanford Hospital & Clinics Stanford, California, United States
  • University of Michigan Comprehensive Cancer Center SC-2 Ann Arbor, Michigan, United States
View all 94 locations
View Trial Details
Completed

Hair Cortisol and Cushing's Disease

NCT04201444

Conditions
Brain Diseases, Central Nervous System Diseases, Cushing Disease, +6 more
Locations
  • Service d'Endocrinologie - CHU Caen Caen, France
  • Service d'endocrinologie - HCL Lyon, France
  • Service d'Endocrinologie, Diabète et Maladies Métaboliques - APHM Marseille, France
  • CIC d'Endocrinologie, Maladies Métaboliques et Nutrition - CHU de Nantes Nantes, France
View Trial Details
Completed

Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease

NCT02697734

Conditions
Brain Diseases, Central Nervous System Diseases, Cushing's Disease, +6 more
Locations
  • University of Colorado Endocrinology Clinical Trials Unit Aurora, Colorado, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Columbia University Medical Center New York Presbyterian Neuroendocrine Unit New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 36 locations
View Trial Details
Completed

Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease

NCT00171951

Conditions
Brain Diseases, Central Nervous System Diseases, Cushing Disease, +6 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Oregon Health & Sciences University Dept.ofOregonHealth&SciencesU. Portland, Oregon, United States
  • University of Pennsylvania Medical Center Philadelphia, Pennsylvania, United States
  • Novartis Investigative Site Paris, France
View Trial Details
Completed

Treatment for Endogenous Cushing's Syndrome

NCT01838551

Conditions
Brain Diseases, Central Nervous System Diseases, Endocrine System Diseases, +6 more
Locations
  • UCLA School of Medicine Los Angeles, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Michigan Medical Center Ann Arbor, Michigan, United States
View all 42 locations
View Trial Details
Completed

Safety and Efficacy of LCI699 in Cushing's Disease Patients

NCT01331239

Conditions
Adrenal Gland Diseases, Adrenocortical Hyperfunction, Brain Diseases, +9 more
Locations
  • Northwestern University Endo, Metabolism and Molecular Chicago, Illinois, United States
  • Massachusetts General Hospital Neuroendocrine Unit Boston, Massachusetts, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • Oregon Health and Science University SC Portland, Oregon, United States
View Trial Details

Related conditions